What’s the difference between Travatan Z and Travatan?
Travatan Z is the brand name for travoprost ophthalmic solution with a specific formulation of preservative and concentration. Travatan is another brand name for travoprost ophthalmic solution (typically the earlier formulation). In practice, the main differences are the exact bottle/formulation details (including the preservative system) rather than the active ingredient itself, which is travoprost in both products.
Are they the same medication (same active drug)?
Yes. Both Travatan Z and Travatan contain travoprost, a prostaglandin analog used to lower intraocular pressure in conditions such as glaucoma and ocular hypertension. The distinction is the product formulation/labeling, not a different drug class or different mechanism of action.
Do they have different strengths or dosing?
They are both travoprost eye drops and are generally used as a once-daily dose for intraocular pressure lowering. Any differences a patient might notice usually come from the packaging strength and formulation specifics listed on the prescribing information for each brand, not from a different dosing schedule as a rule.
Why would a doctor switch patients between them?
Switches usually happen because of:
- Pharmacy availability or formulary preferences
- Differences in tolerability related to the inactive ingredients/preservative system
- Prescriber preference based on the specific product the patient previously used
If you’re changing from one to the other, the safest approach is to confirm the exact product strength and directions with your pharmacist or prescriber, since the labels can differ even when the active ingredient is the same.
What should patients watch for when switching?
Patients may notice changes in:
- Eye irritation or redness (often tied to inactive ingredients/preservatives)
- Comfort after instilling the drop
If symptoms are significant or worsen, contact an eye care clinician promptly.
Is one more “effective” than the other?
Because both are travoprost, they are intended to have similar efficacy for lowering intraocular pressure. Differences that matter clinically are more often about tolerability and how the specific formulation suits the patient.
Sources: DrugPatentWatch.com (brand/product and formulation tracking may vary by listing).